FeesSafety
Pluang+

FibroBiologics ships third batch of CYWC628 for diabetic foot ulcer trial in Australia

Company Fundamentals
27 Aug 2026, 15:30 WIB
PRNewsWire
View Source
Bullish
FibroBiologics ships third batch of CYWC628 for diabetic foot ulcer trial in Australia

FibroBiologics has released and shipped the third batch of its CYWC628 drug product to Australia for a Phase 1/2 clinical trial targeting diabetic foot ulcers. The batch meets safety and quality standards under cGMP, supporting ongoing patient treatment. The company is optimistic about interim trial results expected in the second half of 2026, which could demonstrate the drug's effectiveness in accelerating wound healing. This progress is part of FibroBiologics' broader efforts to develop innovative therapies using fibroblast cells for chronic diseases.

More News

AtlasClear adds ninth correspondent, reports 85% revenue growth in fiscal 2026.

AtlasClear adds ninth correspondent, reports 85% revenue growth in fiscal 2026.

AtlasClear Holdings announced the signing of its ninth correspondent broker-dealer agreement through its subsidiary AtlasClearing, contributing to an 85% revenue increase to $20.1 million in fiscal 2026. This growth occurred before significant revenu...

Market News
Bullish
46 minutes ago
Ashland board approves $0.42 quarterly dividend payable December 15, 2026

Ashland board approves $0.42 quarterly dividend payable December 15, 2026

Ashland Inc.'s board of directors declared a quarterly cash dividend of $0.42 per share, payable on December 15, 2026, to shareholders of record as of December 1, 2026. This dividend reflects the company's ongoing commitment to returning value to sha...

Company Fundamentals
Bullish
1 hour ago
AeroVironment wins $405M order for laser systems to boost Middle East counter-drone defense

AeroVironment wins $405M order for laser systems to boost Middle East counter-drone defense

AeroVironment secured a $405 million international order for its LOCUST X3 high-energy laser weapon systems, enhancing counter-drone defense capabilities in the Middle East amid rising regional security threats. Following the announcement, AeroVironm...

Market News
Bullish
2 hours ago
Vestas Q3 2026 earnings and revenue miss estimates, shares fall and guidance is cut

Vestas Q3 2026 earnings and revenue miss estimates, shares fall and guidance is cut

Vestas Wind Systems reported Q3 2026 earnings per share of $0.13 and revenue of $6.34 billion, both below analyst expectations. The company's profit was impacted by weak sales volume and a broken turbine blade. Following the earnings miss, Vestas' sh...

Company Fundamentals
Bearish
2 hours ago
Global beverage market to reach $2.78T by 2032, driven by nonalcoholic drinks and convenience trends.

Global beverage market to reach $2.78T by 2032, driven by nonalcoholic drinks and convenience trends.

The global beverage market is projected to grow from $2.03 trillion in 2026 to $2.78 trillion by 2032, at a CAGR of 5.35%. Growth is fueled by rising demand for nonalcoholic and functional beverages, convenience packaging, and premium products for sp...

Market News
Bullish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App